Australian and New Zealand Journal of Surgery · 1999 · 43 citations · 12 references
MedicineNuclear MedicineRadiologyDiagnostic ImagingDiagnostic Nuclear MedicineDiagnostic RadiologyParathyroid Adenoma LocalizationParathyroid DisordersParathyroid ImagingParathyroid LocalizationParathyroid NeoplasmsParathyroid SurgeryLocalization In Primary HyperparathyroidismParathyroid Localization ImagingParathyroid Tumor DiagnosisParathyroid UltrasonographyParathyroid UltrasoundSestamibi Parathyroid ImagingSubtraction ScintigraphyTc-99m Dimercaptosuccinic Acid Scintigraphy
BACKGROUND: The diagnostic ability of 99mTc-sestamibi was compared with other techniques and the mechanism of parathyroid uptake was investigated. METHODS: Double-phase 99mTc-sestamibi scanning was performed in 52 primary and 28 renal hyperparathyroidism patients. Gene expressions of mdr1 and mrp were examined by reverse transcriptase polymerase chain reaction in parathyroid tissue. RESULTS: The sensitivity of 99Tc-sestamibi in primary and renal hyperparathyroidism was 91% and 75%, respectively, higher than for ultrasonography, T1/Tc subtraction scintigraphy, or computed tomography. Early 99mTc-sestamibi uptake was washed out in delayed images in 7% and 30% of glands in primary and renal hyperparathyroidism, respectively. Expression of mdr1 and mrp mRNA was found in 5 of 23 and 16 of 31 glands, respectively, and their expression correlated with washout in delayed images. CONCLUSION: 99mTc-sestamibi was the best localization test. mdr1 and mrp were associated with 99Tc-sestamibi washout, but their role in the parathyroid remains unclear.
12
Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex.
David Piwnica‐Worms, Mark L. Chiu, Mark Budding et al. · PubMed · 1993 · 517 citations
Medicine, Oncology, Pharmacology +14
Adela T. Casas, George Burke, Sathyanarayana et al. · The American Journal of Surgery · 1993 · 103 citations
John P. Wei, George Burke, Arlie R. Mansberger · Annals of Surgery · 1994 · 84 citations